Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Journal of Neuroimmunology
|
December 1, 1996
Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis
S J Piddlesden, S Jiang, J L Levin, et al.
Texas Medicine
|
October 26, 1999
The Texarkana mercury incident
L K Lowry, P P Rountree, J L Levin, et al.
Clinical and Experimental Immunology
|
November 14, 1997
Local therapy with soluble complement receptor 1 (sCR1) suppresses inflammation in rat mono-articular arthritis
R M Goodfellow, A S Williams, J L Levin, et al.
Occupational and Environmental Medicine
|
January 1, 2000
Asbestosis and small cell lung cancer in a clutch refabricator
J L Levin, M F O'Sullivan, C J Corn, et al.
Lung
|
January 1, 1993
Airflow obstruction in nonsmoking, asbestos- and mixed dust-exposed workers
D E Griffith, J G Garcia, R F Dodson, et al.
Autoimmunity
|
January 1, 1996
The effect of soluble complement receptor 1 (sCR1) and human thyroid antibodies on the course of experimental autoimmune thyroiditis in rats
R A Metcalfe, R S McIntosh, B P Morgan, et al.
American Journal of Industrial Medicine
|
January 1, 1992
Asbestos exposures: known and underrecognized sources
J L Levin, J M Stocks, J R Shepherd, et al.
Toxicology and Industrial Health
|
January 1, 1991
Asbestos-related disease in employees of a steel mill and a glass bottle manufacturing plant
R S Kronenberg, J L Levin, R F Dodson, et al.
Clinical and Experimental Immunology
|
December 22, 1999
Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis
R M Goodfellow, A S Williams, J L Levin, et al.
Annals of the New York Academy of Sciences
|
December 31, 1991
Asbestos-related disease in employees of a steel mill and a glass bottle-manufacturing plant
R S Kronenberg, J L Levin, R F Dodson, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Journal of Neuroimmunology
|
December 1, 1996
Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis
S J Piddlesden, S Jiang, J L Levin, et al.
Texas Medicine
|
October 26, 1999
The Texarkana mercury incident
L K Lowry, P P Rountree, J L Levin, et al.
Clinical and Experimental Immunology
|
November 14, 1997
Local therapy with soluble complement receptor 1 (sCR1) suppresses inflammation in rat mono-articular arthritis
R M Goodfellow, A S Williams, J L Levin, et al.
Occupational and Environmental Medicine
|
January 1, 2000
Asbestosis and small cell lung cancer in a clutch refabricator
J L Levin, M F O'Sullivan, C J Corn, et al.
Lung
|
January 1, 1993
Airflow obstruction in nonsmoking, asbestos- and mixed dust-exposed workers
D E Griffith, J G Garcia, R F Dodson, et al.
Autoimmunity
|
January 1, 1996
The effect of soluble complement receptor 1 (sCR1) and human thyroid antibodies on the course of experimental autoimmune thyroiditis in rats
R A Metcalfe, R S McIntosh, B P Morgan, et al.
American Journal of Industrial Medicine
|
January 1, 1992
Asbestos exposures: known and underrecognized sources
J L Levin, J M Stocks, J R Shepherd, et al.
Toxicology and Industrial Health
|
January 1, 1991
Asbestos-related disease in employees of a steel mill and a glass bottle manufacturing plant
R S Kronenberg, J L Levin, R F Dodson, et al.
Clinical and Experimental Immunology
|
December 22, 1999
Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis
R M Goodfellow, A S Williams, J L Levin, et al.
Annals of the New York Academy of Sciences
|
December 31, 1991
Asbestos-related disease in employees of a steel mill and a glass bottle-manufacturing plant
R S Kronenberg, J L Levin, R F Dodson, et al.
Page
of 5